ARES
Ares Management Corp
$140.15-0.97%
Setup
Watch
Buy Zone
$142.14-$149.25
Sector
Asset Management
Industry
Asset Management
20
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
ARES chart
Loading chart…
ADX
Weak or Absent16.1Long Term
Range →Intermediate Term
Range →Short Term
Range →Overall Quality20
RS Rating
13
relative strength
Fundamentals
50
Weak fund-Q
Volume Demand
45
-55% vs avg
Technical Setup
50
4/8 checks
Industry/Theme
91
Asset Management
Trade Plan
Avoid
Entry
$142.14
Entry Zone
$142.14-$149.25
Stop / Risk
$130.77
RS Rating
13
Volume confirmed
No
Targets
$170.57 / $177.68
Breakout · IBD Setup
4 ✓ 4 ✗
Entry $142.14–$149.25Stop $130.77Target $170.57 / $177.68
Market regimeUptrend
Quality20
RS Rating13
Above 50-MA+6.95%
Above 200-MA+5.19%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
20
MarketUptrend
SetupWatch
ConfidenceExperimental · not backtested
Fund-Q50 · Weak
StatusAvoid
Stock Data
52-Week Range96 – 187
Price % Chg YTD-13.29%
Price % Chg 4wk1.43%
50-Day Avg Vol2.2 Mil
P/E Ratio63.9
Market Cap$46B
SectorFinancial
IndustryAsset Management
Company Fundamentals
EPS % Chg (Qtr)7.13%
Sales % Chg (Qtr)12.55%
EPS Growth 5y15.13%
Sales Growth 5y31.69%
Annual ROE14.13%
Gross Margin78.9%
Operating Margin30.39%
Net Margin6.96%
Debt / Equity3.75
Setup levels
Current price
$140.15
Pivot
$142.14
Distance to buy
-25%
52-week range
95.8-186.84
Trigger evidence
No active trigger evidence available.
Financial health checks
2/5
Return on equity above 15%
ROE 14.13%
Net margin above 10%
Net margin 6.96%
EPS growing quarter on quarter
EPS q/q 7.13%
Sales growing quarter on quarter
Sales q/q 12.55%
Debt to equity below 1.0
D/E 3.75
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE14.13%
vs sector +0.0%
Net margin6.96%
vs sector -12.6%
Gross margin78.9%
vs sector +4.3%
EPS growth q/q7.13%
vs sector -25.4%
Sales growth q/q12.55%
vs sector -4.1%
Debt / equity3.75
vs sector +0.70
Business quality
50
GradeWeak
EPS rating41
P/E63.9
Market cap$46B
IndustryAsset Management
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-09-06
Trigger date
—
Days on list
1
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.